Pfizer Positive Phase 3 Results for Etrasimod in Ulcerative Colitis

(PLX AI) – Pfizer announces positive top-line results for Phase 3 Trial of Etrasimod in Ulcerative Colitis patients.Patients achieved statistically significant improvements in the primary endpoint of clinical remission at week 12 as compared with …